Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Total Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H has a market cap or net worth of HK$36.45B. The enterprise value is HK$0.00.
Market CapHK$36.45B
Enterprise ValueHK$0.00
Share Statistics
Shanghai Junshi Biosciences Co., Ltd. Class H has 260,295,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding260,295,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Junshi Biosciences Co., Ltd. Class H’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -14.74%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-14.74%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee755.75K
Profits Per Employee-496.87K
Employee Count2,578
Asset Turnover0.18
Inventory Turnover0.70
Valuation Ratios
The current PE Ratio of Shanghai Junshi Biosciences Co., Ltd. Class H is ―. Shanghai Junshi Biosciences Co., Ltd. Class H’s PEG ratio is 0.19.
PE Ratio―
PS Ratio5.50
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-5.04
Price to Operating Cash Flow-59.19
PEG Ratio0.19
Income Statement
In the last 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H had revenue of 1.95B and earned -1.28B in profits. Earnings per share was -1.30.
Revenue1.95B
Gross Profit1.54B
Operating Income-1.34B
Pretax Income-1.36B
Net Income-1.28B
EBITDA-935.50M
Earnings Per Share (EPS)-1.30
Cash Flow
In the last 12 months, operating cash flow was -681.74M and capital expenditures -602.19M, giving a free cash flow of -1.28B billion.
Operating Cash Flow-681.74M
Free Cash Flow-1.28B
Free Cash Flow per Share-4.93
Dividends & Yields
Shanghai Junshi Biosciences Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.69
52-Week Price Change77.57%
50-Day Moving Average25.16
200-Day Moving Average23.46
Relative Strength Index (RSI)33.80
Average Volume (3m)7.63M
Important Dates
Shanghai Junshi Biosciences Co., Ltd. Class H upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateOct 29, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Shanghai Junshi Biosciences Co., Ltd. Class H as a current ratio of 1.72, with Debt / Equity ratio of 57.68%
Current Ratio1.72
Quick Ratio1.48
Debt to Market Cap0.27
Net Debt to EBITDA-0.46
Interest Coverage Ratio-26.07
Taxes
In the past 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H has paid 22.55M in taxes.
Income Tax22.55M
Effective Tax Rate-0.02
Enterprise Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H EV to EBITDA ratio is -11.91, with an EV/FCF ratio of -5.25.
EV to Sales5.72
EV to EBITDA-11.91
EV to Free Cash Flow-5.25
EV to Operating Cash Flow-7.77
Balance Sheet
Shanghai Junshi Biosciences Co., Ltd. Class H has HK$3.57B in cash and marketable securities with HK$3.92B in debt, giving a net cash position of -HK$344.52M billion.
Cash & Marketable SecuritiesHK$3.57B
Total DebtHK$3.92B
Net Cash-HK$344.52M
Net Cash Per Share-HK$1.32
Tangible Book Value Per ShareHK$5.51
Margins
Gross margin is 77.24%, with operating margin of -68.72%, and net profit margin of -65.75%.
Gross Margin77.24%
Operating Margin-68.72%
Pretax Margin-69.68%
Net Profit Margin-65.75%
EBITDA Margin-48.02%
EBIT Margin-62.21%
Analyst Forecast
The average price target for Shanghai Junshi Biosciences Co., Ltd. Class H is HK$27.35, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetHK$27.35
Price Target Upside21.66% Upside
Analyst ConsensusModerate Sell
Analyst Count2
Revenue Growth Forecast38.56%
EPS Growth Forecast48.26%